Please login to the form below

Not currently logged in
Email:
Password:

buprenorphine

This page shows the latest buprenorphine news and features for those working in and with pharma, biotech and healthcare.

Troubled Alkermes eyes November OK for new antipsychotic

Troubled Alkermes eyes November OK for new antipsychotic

and buprenorphine – saying that there wasn’t enough evidence to show it was clinically effective.

Latest news

More from news
Approximately 1 fully matching, plus 22 partially matching documents found.

Latest Intelligence

  • As the opioid crisis grabs the headlines, the search for safe treatments continues As the opioid crisis grabs the headlines, the search for safe treatments continues

    Indivior discovered buprenorphine, sold it under the brand name Subutex to treat opioid addiction in 1996 and has since expanded its portfolio with Suboxone tablets, Suboxone Film, the monthly injectable Sublocade ... of buprenorphine that addresses the

  • Drug launches to watch in 2019 Drug launches to watch in 2019

    CAM2038 is an injectable solution that slowly releases buprenorphine – the most common drug used to treat opioid addiction – into the body, eliminating the need for daily dosages as well as the

  • Pharma deals during December 2012 Pharma deals during December 2012

    deal? Coincidentally, the third late stage deal this month is also an analgesic, a buprenorphine implant lasting for six months for maintenance treatment of opioid dependence; the NDA was submitted in ... 335. Titan / Braeburn. Commercialisation and

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Bedrock Healthcare Communications

Bedrock Healthcare Communications is an award-winning, independent agency founded in 2011. We partner with healthcare professionals, patients, and global pharmaceutical...

Latest intelligence

Virtual MSL/Sales training programs and events
Top 10 ways to leverage the Impetus InSite Platform® for internal MSL/Sales training programs and events...
6 trends shaping the future of personalized medicine
Senior Consultant Leah Carlisle explores the key trends discussed at the 16th annual Personalized Medicine Conference, providing expert analysis and key recommendations for biopharmaceutical innovators....
Omnichannel strategies to revolutionize the healthcare professional experience
Fishawack Health’s omnichannel experts unite to reveal how medical and commercial teams can build more meaningful experiences for healthcare professionals. They discuss the opportunities of omnichannel and explore how the...